International Commitments for Test Data Protection and Their Limits in the Context of Access to Medicines amid a Pandemic Situation: The Case of COVID-19 Pandemic
Lecturer, Department of Law, the University of Dhaka
摘要
Test data protection for the data that is submitted to governments by the originator of medicine is a contentious issue of intellectual property. The need for the protection of test data arises when the national authorities require the test data from the originator companies for the marketing authorization of medicinal products. The Agreement on Trade-Related Aspects of Intellectual Property Rights (hereinafter “TRIPS”), under Article 39.3, has provided an international standard of test data protection. This protection provision of test data creates an additional layer of protection for the medicine irrespective of patent protection, whereby it controls the affordability and accessibility of life-saving drugs. While TRIPS Article 39.3 obligates World Trade Organization (WTO) Members to protect pharmaceutical test data against “unfair commercial use” and “disclosure,” the Agreement’s inherent flexibilities-particularly its public health safeguards and national security exceptions-provide critical pathways to override these obligations during pandemics. This paper uniquely argues that the COVID-19 crisis (and future pandemics) constitutes an “emergency in international relations” under TRIPS Article 73(b)(iii), enabling states to suspend test data protection to expedite access to medicines.
Abstract
Test data protection for the data that is submitted to governments by the originator of medicine is a contentious issue of intellectual property. The need for the protection of test data arises when the national authorities require the test data from the originator companies for the marketing authorization of medicinal products. The Agreement on Trade-Related Aspects of Intellectual Property Rights (hereinafter “TRIPS”), under Article 39.3, has provided an international standard of test data protection. This protection provision of test data creates an additional layer of protection for the medicine irrespective of patent protection, whereby it controls the affordability and accessibility of life-saving drugs. While TRIPS Article 39.3 obligates World Trade Organization (WTO) Members to protect pharmaceutical test data against “unfair commercial use” and “disclosure,” the Agreement’s inherent flexibilities-particularly its public health safeguards and national security exceptions-provide critical pathways to override these obligations during pandemics. This paper uniquely argues that the COVID-19 crisis (and future pandemics) constitutes an “emergency in international relations” under TRIPS Article 73(b)(iii), enabling states to suspend test data protection to expedite access to medicines.
關鍵詞
- 類型
- 論文
- 期刊
- Asian Journal of WTO & International Health Law and policy
- ISSN
- 1819-5164
- 卷期
- 21卷2期
- 出版
- 2026年09月
- 頁碼
- 435–468
- 編號
- NTUEJ00000005
同期目錄
- Evaluating National Security Measures Through the Prism of Defensive and Offensive DeploymentJoel Slawotsky・頁 287–333
- Legal and Economic Analysis of US Antidumping Rules on Global Overcapacity as a Particular Market SituationKyounghwa Kim & Jaeyoun Roh・頁 335–364
- The Risk of Investor-State Arbitration Arising from Renewable Energy Subsidy Schemes: A Caveat for Asian CountriesChen Yu・頁 365–400
- Reconstructing Enforcement in Global Health Law: Sovereignty, Incentives, and the Structural Limits of the International Health RegulationsMohammad Omar Alhejaili & Ibrahim Mathker Alotaibi・頁 401–434
- International Commitments for Test Data Protection and Their Limits in the Context of Access to Medicines amid a Pandemic Situation: The Case of COVID-19 PandemicMoniruz Zaman・頁 435–468
- Were Border Control Measures Helpful for Containing Covid-19? A Time-Series AnalysisShun-Wen Wu・頁 469–514
- A Book Review of Chang Fa Lo Unlocking WTO Decision-Making: Rebuilding Cooperative Consensus Culture to Remedy the Efficiency Deficit (Springer Nature Singapore, 2026)Lisa Toohey・頁 515–522